# | Title | Journal | Year | Citations |
---|
1 | Cytokines and HIV-1: Interactions and Clinical Implications | Antiviral Chemistry and Chemotherapy | 2001 | 280 |
2 | Regiospecific Synthesis and Anti-Human Immunodeficiency Virus Activity of Novel 5-Substituted N-Alkylcarbamoyl and N,N-Dialkyl Carbamoyl 1,2,3-Triazole-TSAO Analogues | Antiviral Chemistry and Chemotherapy | 1998 | 216 |
3 | HPMPC (cidofovir), PMEA (adefovir) and Related Acyclic Nucleoside Phosphonate Analogues: A Review of their Pharmacology and Clinical Potential in the Treatment of Viral Infections | Antiviral Chemistry and Chemotherapy | 1997 | 214 |
4 | Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice | Antiviral Chemistry and Chemotherapy | 2006 | 203 |
5 | Amino Acid Ester Prodrugs of Acyclovir | Antiviral Chemistry and Chemotherapy | 1992 | 194 |
6 | Structural Features and Antiviral Activity of Sulphated Fucans from the Brown Seaweed Cystoseira Indica | Antiviral Chemistry and Chemotherapy | 2007 | 164 |
7 | Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to Penciclovir | Antiviral Chemistry and Chemotherapy | 1993 | 156 |
8 | Nanoparticulate Delivery Systems for Antiviral Drugs | Antiviral Chemistry and Chemotherapy | 2010 | 154 |
9 | Pharmacokinetics of Famciclovir in Man | Antiviral Chemistry and Chemotherapy | 1993 | 136 |
10 | Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern | Antiviral Chemistry and Chemotherapy | 1993 | 132 |
11 | Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-Hydroxycytidine | Antiviral Chemistry and Chemotherapy | 2004 | 127 |
12 | Resistance of Hepatitis B Virus to Antiviral Drugs: Current Aspects and Directions for Future Investigation | Antiviral Chemistry and Chemotherapy | 2001 | 124 |
13 | Cidofovir, a New Agent with Potent Anti-Herpesvirus Activity | Antiviral Chemistry and Chemotherapy | 1996 | 123 |
14 | The Herpesvirus Proteases as Targets for Antiviral Chemotherapy | Antiviral Chemistry and Chemotherapy | 2000 | 115 |
15 | Polyanions — A Lost Chance in the Fight against HIV and other Virus Diseases? | Antiviral Chemistry and Chemotherapy | 2000 | 114 |
16 | Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom | Antiviral Chemistry and Chemotherapy | 1999 | 113 |
17 | Nucleosides for the treatment of respiratory RNA virus infections | Antiviral Chemistry and Chemotherapy | 2018 | 113 |
18 | Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses | Antiviral Chemistry and Chemotherapy | 2018 | 113 |
19 | Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models | Antiviral Chemistry and Chemotherapy | 2004 | 112 |
20 | Synthesis, in Vitro Biological Evaluation and Oral Bioavailability of 9-[2-(Phosphonomethoxy)Propyl]Adenine (PMPA) Prodrugs | Antiviral Chemistry and Chemotherapy | 1997 | 111 |
21 | Anti-Human Immunodeficiency Virus Drug Combination Strategies | Antiviral Chemistry and Chemotherapy | 1998 | 110 |
22 | Inhibition of Hepatitis C Replicon RNA Synthesis by β-D-2′-deoxy-2′-fluoro-2′-C-Methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication | Antiviral Chemistry and Chemotherapy | 2006 | 110 |
23 | Mechanisms of Action of Ribavirin in Antiviral Therapies | Antiviral Chemistry and Chemotherapy | 2001 | 109 |
24 | The Application and Mechanism of Action of Ribavirin in Therapy of Hepatitis C | Antiviral Chemistry and Chemotherapy | 2012 | 109 |
25 | CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection | Antiviral Chemistry and Chemotherapy | 2005 | 106 |
26 | Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration | Antiviral Chemistry and Chemotherapy | 2019 | 100 |
27 | Inhibition of HIV Infection by Caffeoylquinic Acid Derivatives | Antiviral Chemistry and Chemotherapy | 1993 | 97 |
28 | The Mode of Action of Penciclovir | Antiviral Chemistry and Chemotherapy | 1993 | 96 |
29 | Activity of a Sulfated Polysaccharide Extracted from the Red Seaweed Aghardhiella Tenera against Human Immunodeficiency Virus and Other Enveloped Viruses | Antiviral Chemistry and Chemotherapy | 1994 | 95 |
30 | Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? | Antiviral Chemistry and Chemotherapy | 2007 | 94 |
31 | Anti-Influenza Virus Activity of Propolis in Vitro and its Efficacy against Influenza Infection in Mice | Antiviral Chemistry and Chemotherapy | 2008 | 92 |
32 | Isolation and Characterization of Novel Human Immunodeficiency Virus Integrase Inhibitors from Fungal Metabolites | Antiviral Chemistry and Chemotherapy | 1999 | 91 |
33 | Antiviral Portrait Series: 4. Polysuifates as Inhibitors of HIV and Other Enveloped Viruses | Antiviral Chemistry and Chemotherapy | 1994 | 90 |
34 | Medicinal Chemistry of Nucleoside Phosphonate Prodrugs for Antiviral Therapy | Antiviral Chemistry and Chemotherapy | 2012 | 90 |
35 | Antiviral Effect of Brassinosteroids against Herpes Virus and Arenaviruses | Antiviral Chemistry and Chemotherapy | 2000 | 86 |
36 | Antiretroviral Therapy in Macrophages: Implication for HIV Eradication | Antiviral Chemistry and Chemotherapy | 2009 | 86 |
37 | Elvitegravir: A New HIV Integrase Inhibitor | Antiviral Chemistry and Chemotherapy | 2009 | 86 |
38 | Laninamivir and its Prodrug, CS-8958: Long-Acting Neuraminidase Inhibitors for the Treatment of Influenza | Antiviral Chemistry and Chemotherapy | 2010 | 86 |
39 | Sulphated Polymers are Potent and Selective Inhibitors of Various Enveloped Viruses, Including Herpes Simplex Virus, Cytomegalovirus, Vesicular Stomatitis Virus, Respiratory Syncytial Virus, and Toga-, Arena- and Retroviruses | Antiviral Chemistry and Chemotherapy | 1990 | 85 |
40 | Epigallocatechin Gallate Inhibits the HIV Reverse Transcription Step | Antiviral Chemistry and Chemotherapy | 2011 | 84 |
41 | Phosphoramidates and phosphonamidates (ProTides) with antiviral activity | Antiviral Chemistry and Chemotherapy | 2018 | 84 |
42 | Synthesis and Antiviral Activities of 1,2,3-triazole Functionalized Thymidines: 1,3-dipolar Cycloaddition for Efficient Regioselective Diversity Generation | Antiviral Chemistry and Chemotherapy | 2005 | 83 |
43 | Treatment of Lethal Vaccinia Virus Respiratory Infections in Mice with Cidofovir | Antiviral Chemistry and Chemotherapy | 2001 | 82 |
44 | 5′-Nor Carbocyclic 5′-Deoxy-5′-(Isobutylthio)Adenosine and a 2′,3′-Dideoxy-2′,3′-Didehydro Derivative | Antiviral Chemistry and Chemotherapy | 2001 | 82 |
45 | Action of Celgosivir (6 O-Butanoyl Castanospermine) against the Pestivirus BVDV: Implications for the Treatment of Hepatitis C | Antiviral Chemistry and Chemotherapy | 2004 | 80 |
46 | Antiviral Activity and Mode of Action Studies of Ribavirin and Mycophenolic Acid against Orthopoxviruses in Vitro | Antiviral Chemistry and Chemotherapy | 2001 | 78 |
47 | In Vitro and in Vivo Activities of T-705 and Oseltamivir against Influenza Virus | Antiviral Chemistry and Chemotherapy | 2003 | 78 |
48 | Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 Infection | Antiviral Chemistry and Chemotherapy | 2008 | 78 |
49 | Novel DL-Galactan Hybrids from the Red Seaweed Gymnogongrus Torulosus are Potent Inhibitors of Herpes Simplex Virus and Dengue Virus | Antiviral Chemistry and Chemotherapy | 2002 | 76 |
50 | Thiopurine Analogue Inhibitors of Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease, a Deubiquitinating and deISGylating Enzyme | Antiviral Chemistry and Chemotherapy | 2009 | 74 |